TCL Archive House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase June 18, 1993
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications January 31, 2014
TCL Archive DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief January 4, 1980
TCL Archive Delayed Prostate Cancer Surgery Poses No Increased Risk For Some Patients February 24, 2006
